Clinical Trial Update: Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tolerability, safety, and efficacy of oral tedizolid for bone and joint infections has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone and Joint Infection

Drugs mentioned

• tedizolid (tedizolid)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Bone and Joint Infection | Phase 2 | Status: COMPLETED | Results posted: 2023-12-13